Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Palisade Bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 22 | 28 | +6 |
| Shares | 766.3K | 1.30M | +537.1K (+70.1%) |
| Value | $2.03M | $1.70M | −$333.0K (−16.4%) |
New holders (9)
Institutions that held Palisade Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 333,954 | $434.0K | 0.12% |
| Renaissance Technologies LLC | 81,135 | $105.0K | 0.00% |
| Northern Trust Corp | 23,186 | $30.0K | 0.00% |
| Jane Street Group, LLC | 22,285 | $29.0K | 0.00% |
| Two Sigma Investments, LP | 14,477 | $19.0K | 0.00% |
| Two Sigma Securities, LLC | 14,493 | $19.0K | 0.00% |
| Gsa Capital Partners LLP | 10,454 | $14.0K | 0.00% |
| Two Sigma Advisers, LP | 10,500 | $14.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,139 | $7.00K | 0.00% |
Sold out (3)
Institutions that held Palisade Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Virtu Financial LLC | 17,612 | $47.0K |
| HighTower Advisors, LLC | 16,666 | $44.0K |
| Citadel Advisors LLC | 10,519 | $28.0K |